Dexamethasone increases αvβ3 integrin expression and affinity through a calcineurin/NFAT pathway

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1833, Issue 12, 2013, Pages 3306-3313

  Faralli, Jennifer A ^a   Gagen, Debjani ^a   Filla, Mark S ^a   Crotti, Tania N ^b   Peters, Donna M ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Calcineurin; Cytoskeleton; Glaucoma; Glucocorticoids; Integrin; Trabecular meshwork

Indexed keywords

CALCINEURIN; CYCLOHEXIMIDE; CYCLOSPORIN A; DEXAMETHASONE; GLUCOCORTICOID; MIFEPRISTONE; TRANSCRIPTION FACTOR NFAT; VITRONECTIN RECEPTOR;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG EFFECT; DRUG HALF LIFE; FLUORESCENCE ACTIVATED CELL SORTING; GLAUCOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SUBUNIT; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84886439194     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2013.09.020     Document Type: Article

References (49)

1. Alghisi G.C., Ruegg C. Vascular integrins in tumor angiogenesis: mediators and therapeutic targets. Endothelium 2006, 13:113-135.
2. Kuphal S., Bauer R., Bosserhoff A.K. Integrin signaling in malignant melanoma. Cancer Metastasis Rev. 2005, 24:195-222.
3. Chen X., Park R., Tohme M., Shahinian A.H., Bading J.R., Conti P.S. MicroPET and autoradiographic imaging of breast cancer alpha v-integrin expression using 18F- and 64Cu-labeled RGD peptide. Bioconjug. Chem. 2004, 15:41-49.
4. Hutchinson J.H., Halczenki W., Brashear K.M., Breslin M.J., Coleman P.J., Duong le T., Fernandez-Metzler C., Gentile M.A., Fisher J.E., Hartman G.D., Huff J.R., Kimmel D.B., Leu C.T., Meissner R.S., Merkle K., Nagy R., Pennypacker B., Perkins J.J., Prueksaritanont T., Rodan G.A., Varga S.L., Wesolowski G.A., Zartman A.E., Rodan S.B., Duggan M.E. Nonpeptide αvβ3 antagonists. 8. In vitro and in vivo evaluation of a potent αvβ3 antagonist for the prevention and treatment of osteoporosis. J. Med. Chem. 2003, 4790-4798.
5. Panchatcharam M., Miriyala S., Yang F., Leitges M., Chrzanowska-Wodnicka M., Quilliam L.A., Anaya P., Morris A.J., Smyth S.S. Enhanced proliferation and migration of vascular smooth muscle cells in response to vascular injury under hyperglycemic conditions is controlled by β3 integrin signaling. Int. J. Biochem. Cell Biol. 2010, 42:965-974.
6. Clemmons D.R., Maile L.A., Ling Y., Yarber J., Busby W.H. Role of the integrin αvβ3 in mediating increased smooth muscle cell responsiveness to IGF-1 in response to hyperglycemic stress. Growth Horm. IGF Res. 2007, 17:265-270.
7. Filla M.S., Schwinn M.K., Nosie A.K., Clark R.W., Peters D.M. Dexamethasone-associated cross-linked actin network formation in human trabecular meshwork cells involves β3 integrin signaling. Invest. Ophthalmol. Vis. Sci. 2011, 52:2952-2959.
8. Filla M.S., Schwinn M.K., Sheibani N., Kaufman P.L., Peters D.M. Regulation of cross-linked actin network (CLAN) formation in human trabecular meshwork (HTM) cells by convergence of distinct β1 and β3 integrin pathways. Invest. Ophthalmol. Vis. Sci. 2009, 50:5723-5731.
9. Filla M.S., Woods A., Kaufman P.L., Peters D.M. β1 and β3 integrins cooperate to induce syndecan-4-containing cross-linked actin networks in human trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 2006, 47:1956-1967.
10. Becker B., Mills D.W. Corticosteroids and intraocular pressure. Arch. Ophthalmol. 1963, 70:500-507.
11. Armaly M.F. Effect of corticosteroids on intraocular and fluid dynamics. I. The effect of dexamethasone in the normal eye. Arch. Ophthalmol. 1963, 70:482-491.
12. Tian B., Geiger B., Epstein D.L., Kaufman P.L. Cytoskeletal involvement in the regulation of aqueous humor outflow. Invest. Ophthalmol. Vis. Sci. 2000, 41:619-623.
13. Faralli J.A., Schwinn M.K., Gonzalez J.M., Filla M.S., Peters D.M. Functional properties of fibronectin in the trabecular meshwork. Exp. Eye Rese. 2009, 88:689-693.
14. Clark A.F., Brotchie D., Read A.T., Hellberg P., English-Wright S., Pang I.H., Ethier C.R., Grierson I. Dexamethasone alters F-actin architecture and promotes cross-linked actin network formation in human trabecular meshwork tissue. Cell Motil. Cytoskeleton 2005, 60:83-95.
15. Clark A.F., Miggans S.T., Wilson K., Browder S., McCartney M.D. Cytoskeletal changes in cultured human glaucoma trabecular meshwork cells. J. Glaucoma 1995, 4:183-188.
16. Clark A.F., Wilson K., McCartney M.D., Miggans S.T., Kunkle M., Howe W. Glucocorticoid-induced formation of cross-linked actin networks in cultured human trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 1994, 35:281-294.
17. Kitazawa S., Ross F.P., McHugh K., Teitelbaum S.L. Interleukin-4 induces expression of the integrin αvβ3 via transactivation of the β3 gene. J. Biol. Chem. 1995, 270:4115-4120.
18. Hayashi H., Kume T. Foxc2 transcription factor as a regulator of angiogenesis via induction of integrin β3 expression. Cell Adh. Migr. 2009, 3:24-26.
19. Hayashi H., Sano H., Seo S., Kume T. The Foxc2 transcription factor regulates angiogenesis via induction of integrin β3 expression. J. Biol. Chem. 2008, 283:23791-23800.
20. Cheng S.L., Lai C.F., Fausto A., Chellaiah M., Feng X., McHugh K.P., Teitelbaum S.L., Civitelli R., Hruska K.A., Ross F.P., Avioli L.V. Regulation of αvβ3 and αvβ5 integrins by dexamethasone in normal human osteoblastic cells. J. Cell. Biochem. 2000, 77:265-276.
21. Crotti T.N., Flannery M., Walsh N.C., Fleming J.D., Goldring S.R., McHugh K.P. NFATc1 regulation of the human β3 integrin promoter in osteoclast differentiation. Gene 2006, 372:92-102.
22. Sun L., Peng Y., Zaidi N., Zhu L.-L., Iqbal J., Yamoah K., Wang X., Liu P., Abe E., Moonga B.S., Epstein S., Zaidi M. Evidence that calcineurin is required for the genesis of bone-resorbing osteoclasts. Am. J. Physiol. Renal Physiol. 2007, 292:F285-F291.
23. Crabtree G.R. Calcium, calcineurin, and the control of transcription. J. Biol. Chem. 2001, 276:2313-2316.
24. Filla M.S., David G., Weinreb R.N., Kaufman P.L., Peters D.M. Distribution of syndecans 1-4 within the anterior segment of the human eye: expression of a variant syndecan-3 and matrix-associated syndecan-2. Exp. Eye Res. 2004, 79:61-74.
25. Clark R.W., Nosie A.K., Walker T., Faralli J.A., Filla M.S., Barrett-Wilt G., Peters D.M. Comparative genomic and proteomic analysis of cytoskeletal changes in dexamethasone-treated trabecular meshwork cells. Mol. Cell. Proteomics 2013, 12:194-206.
26. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:2002-2007.
27. Nguyen T.D., Chen P., Huang W.D., Chen H., Johnson D., Polansky J.R. Gene structure and properties of TIGR, a olfactomedin-related glycoprotein cloned from glucocorticoid-induced trabecular meshwork cells. J. Biol. Chem. 1998, 273:6341-6350.
28. Reynolds P.D., Roveda K.P., Tucker J.A., Moore C.M., Valentine D.L., Scammell J.G. Glucocorticoid-resistant B-lymphoblast cell line derived from the Bolivian squirrel monkey (Saimiri boliviensis boliviensis). Lab. Anim. Sci. 1998, 48:364-370.
29. Baughman G., Wiederrecht G.J., Chang F., Martin M.M., Bourgeois S. Tissue distribution and abundance of human FKBP51 and FK506-binding protein that can mediate calcineurin inhibition. Biochem. Biophys. Res. Commun. 1997, 232:437-443.
30. Nehme A., Lobenhofer E.K., Stamer W.D., Edelman J.L. Glucocorticoids with different chemical structures but similar glucocorticoid receptor potency regulate subsets of common and unique genes in human trabecular meshwork cells. BMC Med. Genomics 2009, 2:58-71.
31. Fryer C.J., Kinyamu H.K., Rogatsky I., Garabedian M.J., Archer T.K. Selective activation of the glucocorticoid receptor by steroid antagonists in human breast cancer and osteosarcoma cells. J. Biol. Chem. 2000, 275:17771-17777.
32. Distelhorst C.W., Howard K.K. Evidence from pulse-chase labeling studies that the antiglucocorticoid hormone RU486 stabilizes the nonactivated form of the glucocorticoid receptor in mouse lymphoma cells. J. Steroid Biochem. 1990, 36:25-31.
33. Bourgeois S., Pfahl M., Baulieu E.E. DNA binding properties of glucocorticosteroid receptors bound to the steroid antagonist RU-486. EMBO J. 1984, 3:751-755.
34. Clever U., Romball C.G. RNA and protein synthesis in the cellular response to a hormone ecdysone. Proc. Natl. Acad. Sci. U. S. A. 1966, 56:1470-1476.
35. Zawawi M.S.F., Dharmapatni A.A.S.S.K., Cantley M.D., McHugh K.P., Haynes D.R., Crotti T.N. Regulation of ITAM adaptor molecules and their receptors by inhibition of calcineurin-NFAT signalling during late stage osteoclast differentiation. Biochem. Biophys. Res. Commun. 2012, 427:404-409.
36. Liu J., Farmer J.D.J., Lane W.S., Friedman J., Weissman I., Schreiber S.L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991, 66:807-815.
37. Schreiber S.L., Crabtree G.R. The mechanism of action of cyclosporin A and FK506. Immunol. Today 2006, 13:136-142.
38. Joe M.K., Sohn S., Kim T.E., Im J., Choi Y.R., Kee C. Analysis of glucocorticoid-induced MYOC expression in human trabecular meshwork cells. Vision Res. 2011, 51:1033-1038.
39. Shepard A.R., Jacobson N., Fingert J.H., Stone E.M., Sheffield V.C., Clark A.F. Delayed secondary glucocorticoid responsiveness of MYOC in human trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 2001, 42:3173-3181.
40. Alward W.L., Fingert J.H., Coote M.A., Johnson A.T., Lerner S.F., Junqua D., Durcan F.J., McCartney P.J., Mackey D.A., Sheffield V.C., Stone E.M. Clinical features associated with mutations in the chromosome 1 open-angle glaucoma gene (GLC1A). N. Engl. J. Med. 1998, 338:1022-1027.
41. Fingert J.H., Jeon E., Liebmann J.M., Yamamoto T., Craig J.E., Rait J., Kawase K., Hoh S.T., Buys Y.M., Dickinson J., Hockey R.R., Williams-Lyn D., Trope G., Kitazawa Y., Ritch R., Mackey D.A., Alward W.L., Sheffield V.C., Stone E.M. Analysis of myocilin mutations in 1703 glaucoma patients from five different populations. Hum. Mol. Genet. 1999, 8:899-905.
42. Stone E.M., Fingert J.H., Alward W.L.M., Nguyen T.D., Polansky J.R., Sunden S.L.F., Nishimura D., Clark A.F., Nystuen A., Nichols B., Mackey D.A., Ritch R., Kalenak J.W., Craven E.R., Sheffield V.C. Identification of a gene that causes primary open angle glaucoma. Science 1997, 275:668-670.
43. Nicolaides N.C., Galata Z., Kino T., Chrousos G.P., Charmandari E. The human glucocorticoid receptor: molecular basis of biologic function. Steroids 2010, 75:1-12.
44. Muzikar K.A., Nickol N.G., Dervan P.B. Repression of DNA-binding dependent glucocorticoid receptor-mediated gene expression. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:16598-16603.
45. Crotti T.N., Sharma S.M., Fleming J.D., Flannery M.R., Ostrowski M.C., Goldring S.R., McHugh K.P. PU.1 and NFATc1 mediate osteoclastic induction of the mouse β3 integrin promoter. J. Cell. Physiol. 2008, 215:636-644.
46. Takayanagi H., Kim S., Koga T., Nishina H., Isshiki M., Yoshida H., Saiura A., Isobe M., Yokochi T., Inoue J., Wagner E.F., Mak T.W., Kodama T., Taniguchi T. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 2002, 3:889-901.
47. Ishida N., Hayashi K., Hoshijima M., Ogawa T., Koga S., Miyatake Y., Kumegawa M., Kimura T., Takeya T. Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. J. Biol. Chem. 2002, 277:41147-41156.
48. Wade N.C., Grierson I., O'Reilly S., Hoare M.J., Cracknell K.P., Paraoan L.I., Brotchie D., Clark A.F. Cross-linked actin networks (CLANs) in bovine trabecular meshwork cells. Exp. Eye Res. 2009, 89:648-659.
49. Ing N.H. Steroid hormones regulate gene expression posttranscriptionally by altering the stabilities of messenger RNAs. Biol. Reprod. 2005, 72:1290-1296.